2020 Revenues ($USD) : $19,410,703,364
2020 Revenues (foreign currencies) : DKK 126946000000
2020 R&D spend : $2,368,105,810
2020 Number of Employees : 45,323
Fiscal Year End : 12/31/2020
Key People : Lars Fruergaard Jørgensen, president and CEO; Monique Carter, EVP and head of people & organization; Maziar Mike Doustdar, EVP and head of international operations; Ludovic Helfgott, EVP and head of biopharm; Karsten Munk Knudsen, EVP and CFO; Doug Langa, EVP and head of North American operations, Martin Holst Lange, EVP, head of development; Marcus Schindler, EVP for research & early development and CSO; Camilla Sylvest, EVP and head of commercial strategy & corporate affairs; Henrik Wulff, EVP and head of product supply, quality & IT

The NovoSeven factory in Hillerød, Denmark. Image courtesy of Novo Nordisk.